IN Brief:
- Average time to issue a first request for further information fell from 195 days to 90 days.
- The Business Support Service has handled 14 requests from nine companies, with two subsequently submitting applications.
- Further guidance on authorisations, labelling, hygiene, production, and compliance is scheduled through January 2027.
Food Standards Agency and Food Standards Scotland have shortened early assessment times for cell-cultivated food applications as their two-year regulatory sandbox moves into its final phase.
The average time taken to issue a first request for further information has fallen from 195 days across applications assessed before the programme to 90 days among applications tracked during the sandbox. Regulators are also expanding the technical and procedural guidance available to businesses preparing applications.
The programme began in 2025 and is due to finish in February 2027. It is intended to improve regulatory understanding of cell-cultivated products while giving developers clearer expectations about the evidence required before products can be authorised for the UK market.
Cell-cultivated foods are produced by growing selected cells under controlled conditions before harvesting and processing them into food ingredients or finished products. The production routes vary between developers, creating assessment questions around cell identity, growth media, microbiological hazards, toxicology, allergens, nutritional composition, production controls, and the consistency of the finished material.
The sandbox does not remove the requirement for a full safety assessment. Instead, the FSA and FSS are using the programme to identify recurring gaps earlier and reduce avoidable exchanges once a formal application has entered assessment.
The first-request figures indicate that part of that process is already moving more quickly. Before the sandbox, the average interval across four applications was 195 days; during the programme, the corresponding figure across three applications has fallen to 90 days.
Application support has developed alongside the assessment work. The Business Support Service has received 14 requests from nine companies, including businesses inside and outside the formal sandbox cohort. Two companies subsequently submitted applications after receiving tailored feedback.
That earlier engagement is particularly relevant in a sector where regulatory evidence is closely tied to production development. Changes to cell lines, growth media, bioreactor conditions, harvesting methods, or downstream processing can alter the safety information required, so gaps identified late in assessment may demand additional laboratory or manufacturing work.
Regulators have therefore been building guidance around the production process as well as the application procedure. Published material has covered product classification, HACCP principles, hygiene requirements, allergenicity, nutrition, product identity, manufacturing processes, and microbiological hazards.
The remaining programme includes further regulatory guidance on authorisations in September 2026, labelling in November, and hygiene, production, and compliance in January 2027. Additional technical work on areas including toxicology and growth media is also being developed.
The breadth of that guidance reflects the variation between cell-cultivated production platforms. Developers may use different source cells, media formulations, vessels, scaffolds, harvesting systems, and downstream processes, leaving regulators to define common evidence requirements without assuming that every application follows the same manufacturing route.
Earlier clarification can influence plant and process design. Analytical methods, raw-material specifications, contamination controls, validation work, and traceability systems are easier to incorporate while a manufacturing process is still being developed than after commercial equipment and operating procedures have been fixed.
The FSA has nevertheless cautioned that assessment speed is not controlled by the regulator alone. Applications can only progress when companies provide sufficiently complete responses to requests for information, and the timetable for completing the first full risk assessments remains dependent on the quality and speed of those submissions.
The wider regulatory setting is also changing as the UK and European Union develop a sanitary and phytosanitary agreement. The eventual arrangement could influence parts of the authorisation framework in Great Britain, although the FSA says the technical outputs from the sandbox will remain relevant to future assessment work.
The programme is therefore concentrating on the mechanics of regulated-product assessment rather than creating a separate approval route for cultivated foods. Faster initial scrutiny, clearer evidence requirements, and earlier discussions with applicants are intended to reduce repeated regulatory exchanges without changing the safety threshold products must meet.
With the sandbox due to end in February 2027, the remaining months will determine how much of that work can be incorporated into routine FSA and FSS assessment. The reduction from 195 days to 90 days provides an early operational measure; completion of the underlying applications will depend on whether applicants can supply the scientific evidence needed to close the remaining assessment questions.
